Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Reform Advocates See Reimport Bill As Model: Is Hatch Obstacle?

Executive Summary

Waxman/Hatch reform legislation could move in the 107th Congress in a fashion similar to the reimportation bill enacted in 2000, Generic Pharmaceutical Association President William Nixon suggested during the Schwab Washington Research Group healthcare conference in Washington, D.C. May 9.

You may also be interested in...



Waxman/Hatch Reform Should Await Pending Supreme Court Decision – Hatch

Congress should wait for an upcoming Supreme Court ruling on the "doctrine of equivalents" before beginning serious work on re-drafting the Waxman/Hatch Act, Sen. Orrin Hatch (R-Utah) said

Waxman/Hatch Reform Should Await Pending Supreme Court Decision – Hatch

Congress should wait for an upcoming Supreme Court ruling on the "doctrine of equivalents" before beginning serious work on re-drafting the Waxman/Hatch Act, Sen. Orrin Hatch (R-Utah) said

Patent Extensions’ Cost To Be Evaluated By FDA Under Ag Approps Request

FDA will report on the costs to consumers of drug patent extensions by March

Related Content

UsernamePublicRestriction

Register

PS037823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel